AKPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akpro, and what generic alternatives are available?
Akpro is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in AKPRO is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
Summary for AKPRO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Patent Applications: | 575 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AKPRO at DailyMed |
US Patents and Regulatory Information for AKPRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epic Pharma Llc | AKPRO | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074382-001 | Sep 29, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |